- 1、本文档共7页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Risperidone and perphenazine in the treatment of senile schizophrenia
PAGE \* MERGEFORMAT 7
Risperidone and perphenazine in the treatment of senile schizophrenia
Of: Luai Yi, Cao Yongkang, Pan Yu Biao
[Abstract] Objective To compare risperidone and perphenazine for schizophrenia and old age security. Methods 68 elderly patients with schizophrenia were randomly divided into two groups, respectively, risperidone or perphenazine treatment of 8 weeks, both groups before and after treatment in the treatment of 2,4,8 weekend with the Positive and Negative Syndrome Scale (PANSS and adverse Symptom Scale (TESS [1] assessed the efficacy and adverse reactions. Results efficient risperidone group 82.4%, perphenazine group was 76.5%, the two groups showed no significant clinical differences (Pgt; 0.05, risperidone group 8 weeks after treatment of negative symptoms sub-group was significantly lower than perphenazine, perphenazine group than in less adverse reactions and light. Conclusion risperidone and perphenazine in the treatment of senile schizophrenia clinical efficacy equivalent, but the negative symptoms of risperidone treatment on efficacy and safety superior to perphenazine.
[Keywords:] risperidone in schizophrenia in old age perphenazine
New atypical antipsychotic drugs on positive and negative symptoms are a therapeutic effect, and adverse drug reaction, in the treatment of mental illness more and more attention. In this paper, perphenazine as a control to compare risperidone in elderly of the efficacy and safety of schizophrenia, are as follows.
Subjects and Methods
1. Objects
All patients from our hospital in January 2007 to 12 months of outpatient or hospitalized patients, are in line with the Chinese Classification and Diagnostic Criteria of Mental Disorders Version 3 (CCMD 3 diagnostic criteria of schizophrenia, agegt; = 60 years old, male or female , 1 week before enrollment did not use antipsychotic medication, PANSS total scoregt; = 60 points, excluding a serious physical illness, alcohol or drug abuse
您可能关注的文档
- Retired health authorities Analysis and Countermeasures.doc
- Retroperitoneal laparoscopic renal cyst clinical application.doc
- Retrograde lacrimal duct lacrimal duct intubation in the treatment of chronic inflammation of the clinical observation of.doc
- Retroperitoneal schwannoma diagnosis and treatment of.doc
- Retroperitoneal laparoscopic surgery and open surgery for primary aldosteronism Comparative Study.doc
- Retroperitoneal laparoscopic radical nephrectomy.doc
- Retroperitoneal spaces reported three cases of appendicitis.doc
- Retrograde sural neurovascular Clinical Application of fasciocutaneous flap_0.doc
- Retrovirus-mediated gene targeting human Slingshot1L stable transfection of human bone marrow mesenchymal stem cell line.doc
- Return bar plate extracts against herpes simplex virus-I type of pharmacological effects of_0.doc
- 地热能源供暖系统运行维护与2025年市场服务研究报告[001].docx
- 2025年公交优先战略视角下城市交通拥堵治理的公共交通与公共交通社会服务能力提升[001].docx
- 基于透明度评估的2025年在线教育推荐算法研究.docx
- 2025年环保产业技术创新驱动产业升级市场策略分析报告[001].docx
- 2025土木工程建筑施工能力提升B卷题库含答案详解(能力提升).docx
- 中国卒中中心建设指南-精品文档.pptx
- 2025年线上职业技能培训课程体系与产业需求匹配度评估报告.docx
- 2025土木工程建筑施工能力提升B卷题库含答案详解(新).docx
- 金融审计智能化变革:2025年AI算法应用案例分析报告[001].docx
- 2025土木工程建筑施工能力提升B卷题库含答案详解【综合题】.docx
文档评论(0)